554 results on '"Ho, Cheryl"'
Search Results
2. Predicting which patients with cancer will see a psychiatrist or counsellor from their initial oncology consultation document using natural language processing
3. Mapping the experiences of people with advanced cancer across multiple cancer types—a scoping review
4. Tensor Radiomics: Paradigm for Systematic Incorporation of Multi-Flavoured Radiomics Features
5. ctDNA response after pembrolizumab in non-small cell lung cancer: phase 2 adaptive trial results
6. “I Just Assumed This Was Already Being Done”: Canadian Patient Preferences for Enhanced Data Sharing for Precision Oncology
7. Improved uptake and survival with systemic treatments for metastatic non-small cell lung cancer: younger versus older adults
8. Outcomes of patients with advanced epithelial growth factor receptor mutant lung cancer treated with first-line osimertinib who would not have met the eligibility criteria for the FLAURA clinical trial
9. The perceptions and adoption of environmentally sustainable practices among anesthesiologists—a qualitative study
10. A Canadian Study of Cisplatin Metabolomics and Nephrotoxicity (ACCENT): A Clinical Research Protocol
11. Moving Towards Integrated Models of Aged Care Across Boundaries in Asia
12. Economic impact of using risk models for eligibility selection to the International lung screening Trial
13. Surgically Resectable Non-Small Cell Lung Cancer: A Contemporary Approach
14. Clonal hematopoiesis of indeterminate potential (CHIP): Outcomes and adverse events in patients with solid tumors.
15. A biomarker-directed, multi-center phase II/III study of ctDNA molecular response adaptive immuno-chemotherapy in patients with non-small cell lung cancer.
16. International recommendations for plasma Epstein-Barr virus DNA measurement in nasopharyngeal carcinoma in resource-constrained settings: lessons from the COVID-19 pandemic
17. Defining a Core Data Set for the Economic Evaluation of Precision Oncology
18. A perspective on life-cycle health technology assessment and real-world evidence for precision oncology in Canada
19. Association between genetic information provision and decisional conflict in patients with cancer.
20. Fathers Talking and Reading with Their 3-Year-Olds During Shared Bookreading
21. High-Ambient Air Pollution Exposure Among Never Smokers Versus Ever Smokers With Lung Cancer
22. Canadian consensus statement on the management of radioactive iodine–resistant differentiated thyroid cancer
23. Patient-reported psychosocial needs and psychological distress predict survival in geriatric oncology patients
24. Comparability of laboratory-developed and commercial PD-L1 assays in non-small cell lung carcinoma
25. Discordance in PD-L1 scores on repeat testing of non-small cell lung carcinomas
26. End-of-Life Health Resource Utilization for Limited English-Proficient Patients With Advanced Non–Small-Cell Lung Cancer
27. Patient-reported outcome measures in patients undergoing radiotherapy for head and neck cancer
28. Patient-reported psychosocial distress in adolescents and young adults with germ cell tumours
29. Improvement of elderly health care voucher scheme in Hong Kong
30. Applicability of the PACIFIC trial results in patients not eligible for the PACIFIC trial: Canadian rapid consensus statement and recommendations.
31. Clonal hematopoiesis of indeterminate potential (CHIP), treatment outcomes and adverse events in gastrointestinal cancers: A pooled analysis of clinical trial and real-world data.
32. Tensor radiomics: paradigm for systematic incorporation of multi-flavoured radiomics features
33. The Game is Afoot – Seeking Early-Stage Lung Cancer Circulating Tumor DNA.
34. Real world duration of curative intent breast, colorectal, non-small cell lung, and prostate cancer treatment
35. Emotional distress and psychosocial needs in patients with breast cancer in British Columbia: younger versus older adults
36. Outcome Differences Between First- and Second-generation EGFR Inhibitors in Advanced EGFR Mutated NSCLC in a Large Population-based Cohort
37. Real-World Treatment of Stage III NSCLC: The Role of Trimodality Treatment in the Era of Immunotherapy
38. Readiness of Healthcare Systems to Generate Real-World Evidence: Reliability of CT Radiographic End Points for Evaluation of First-Line Systemic Treatment
39. Mother–infant shared book reading in the first year of life
40. The Game is Afoot – Seeking Early-Stage Lung Cancer Circulating Tumor DNA
41. Radical Treatment of Stage II Non–small-cell Lung Cancer With Nonsurgical Approaches: A Multi-institution Report of Outcomes
42. Beyond PACIFIC: Real-World Outcomes of Adjuvant Durvalumab According to Treatment Received and PD-L1 Expression
43. A protocol for a systematic review with prospective individual patient data meta-analysis in EGFR mutant NSCLC with brain metastases to assess the effect of SRS + Osimertinib compared to Osimertinib alone: the STARLET collaboration
44. Real-World Clinical Outcomes for Patients with EGFR and HER2 Exon 20 Insertion-Mutated Non-Small-Cell Lung Cancer
45. Prediction of Disease Progression to Upfront Pembrolizumab Monotherapy in Advanced Non-Small-Cell Lung Cancer with High PD-L1 Expression Using Baseline CT Disease Quantification and Smoking Pack Years
46. Population-based analysis of curative therapies in stage II non-small cell lung cancer: the role of radiotherapy in medically inoperable patients
47. Survival Implications of De Novo Versus Recurrent Metastatic Non–Small Cell Lung Cancer
48. Real-World Outcomes of Stage IV NSCLC with PD-L1 ≥ 50% Treated with First-Line Pembrolizumab: Uptake of Second-Line Systemic Therapy
49. Abstract CT212: A ctDNA-directed, multi-center phase II study of molecular response adaptive immuno-chemotherapy in patients with non-small cell lung cancer: Analysis of Stage 1 of CCTG BR.36
50. ARIN Announces the Academy of The Association of Radiologic and Imaging Nursing (AARIN) and Fellows Program
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.